<DOC>
	<DOCNO>NCT00692185</DOCNO>
	<brief_summary>This study evaluate effectiveness antipsychotic medication olanzapine treat outpatient anorexia nervosa .</brief_summary>
	<brief_title>Effectiveness Olanzapine Versus Placebo Treating Outpatients With Anorexia Nervosa</brief_title>
	<detailed_description>Anorexia nervosa ( AN ) disease disorder eat characterize self-starvation , extreme weight loss , difficulty maintain normal weight . Symptoms behavior AN may include distorted body image , obsessive exercise , lack menstruation among woman , binge purge eat behavior , intense fear weight gain . Furthermore , people AN high risk mental disorder , depression anxiety , medical complication , organ damage , heart failure , osteoporosis . Current treatment AN include nutrition counseling , psychotherapy , medication . Although weight restoration treatment priority , particular therapeutic approach patient AN clear empirical support . Previous study suggest certain medication usually use treat schizophrenia , also know atypical antipsychotic drug , may helpful increase appetite reduce anxiety relate weight gain eat people AN . Specifically , atypical antipsychotic medication olanzapine may effective improve overall symptom AN restore weight normal level . This study compare effectiveness antipsychotic medication olanzapine versus placebo treat outpatient AN . Participation study last 8 week . All participant first undergo baseline assessment include questionnaire interview AN symptom , physical exam , vital sign measurement , electrocardiograph ( EKG ) , blood draw . Participants assign randomly 8 week daily treatment olanzapine placebo . Participants meet study doctor weekly 8 week treatment . During visit , study doctor monitor participant ' progress , medication dosage , vital sign , side effect . Participants also fill weekly questionnaire status condition monthly repeat baseline questionnaire . In addition , participant undergo blood draw every 2 week first month study every 4 week remainder study . Upon complete 8 week treatment , participant repeat baseline assessment . During next 5 year , participant may contact complete follow-up interview .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Meets DSMIV criterion ( include amenorrhea ) AN Body mass index ( BMI ) less 19 kg/m2 great 14 kg/m2 Patient ( family patient minor ) refuse hospitalization Free psychotropic medication ( 4 week medication free fluoxetine antipsychotic medication ; 2 week medication free others ) OR stable dose SSRI SNRI ( venlafaxine ) 4 week study entry Prior treatment AN Any medical psychiatric problem require urgent attention and/or significant comorbid illness likely benefit propose treatment Allergy olanzapine Significant orthostatic high blood pressure Recent commencement psychotherapy community Diabetes mellitus , fast serum glucose great 120 mg/dL nonfasting serum glucose great 140 mg/dL Known history current past jaundice Known history narrow angle glaucoma Active substance abuse dependence Schizophrenia , schizophreniform disorder , bipolar illness Movement disorder presence tic History tardive dyskinesia History seizures Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Anorexia Nervosa</keyword>
</DOC>